Literature DB >> 30505762

Comment on "Refining Dynamic Risk Stratification and Prognostic Groups for Differentiated Thyroid Cancer With TERT Promoter Mutations".

Ashok R Shaha1.   

Abstract

Entities:  

Year:  2018        PMID： 30505762      PMCID： PMC6234240          DOI： 10.21037/gs.2018.06.02

Source DB:  PubMed          Journal:  Gland Surg        ISSN： 2227-684X


× No keyword cloud information.
  4 in total

1.  BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.

Authors:  Mingzhao Xing; Rengyun Liu; Xiaoli Liu; Avaniyapuram Kannan Murugan; Guangwu Zhu; Martha A Zeiger; Sara Pai; Justin Bishop
Journal:  J Clin Oncol       Date:  2014-07-14       Impact factor: 44.544

2.  TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer.

Authors:  Xiaoli Liu; Shen Qu; Rengyun Liu; Chunjun Sheng; Xiaoguang Shi; Guangwu Zhu; Avaniyapuram Kannan Murugan; Haixia Guan; Hongyu Yu; Yangang Wang; Hui Sun; Zhongyan Shan; Weiping Teng; Mingzhao Xing
Journal:  J Clin Endocrinol Metab       Date:  2014-03-11       Impact factor: 5.958

3.  Refining Dynamic Risk Stratification and Prognostic Groups for Differentiated Thyroid Cancer With TERT Promoter Mutations.

Authors:  Tae Hyuk Kim; Chang-Seok Ki; Hye Seung Kim; Kyunga Kim; Jun-Ho Choe; Jung-Han Kim; Jee Soo Kim; Young Lyun Oh; Soo Yeon Hahn; Jung Hee Shin; Hye Won Jang; Sun Wook Kim; Jae Hoon Chung
Journal:  J Clin Endocrinol Metab       Date:  2017-05-01       Impact factor: 5.958

Review 4.  TERT promoter mutations in thyroid cancer.

Authors:  Rengyun Liu; Mingzhao Xing
Journal:  Endocr Relat Cancer       Date:  2016-01-05       Impact factor: 5.678
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.